Page 1

orexo Develops improved pharmaceuticals and digital therapies addressing unmet within the growing space of substance use disorders and mental health Interim Report Q1 April 29th 2021 Nasdaq Stockholm : ORX US OTC Market : ORXOY ( ADR ) WORK